More PRNewswire
View Older Stories View Newer Stories-
Norfolk Southern customers: we support the company and its strategy
-
Wheels Up Appoints Dave Harvey as Chief Commercial Officer
-
XM Cyber Report Finds 80% of Security Exposures are Fueled by Misconfigurations
-
World Lupus Federation Global Survey Finds 91% of People with Lupus Report Using Oral Steroids to Treat Lupus
-
Resideo to Participate at Upcoming Investor Conferences
-
CPS ENERGY ENTERS INTO AGREEMENT FOR ADDITIONAL OWNERSHIP OF THE SOUTH TEXAS NUCLEAR PROJECT AND ADDS 200 MEGAWATTS OF CAPACITY FOR GROWING SAN ANTONIO COMMUNITY
-
ZygoFix Receives FDA Clearance for its zLOCK Lumbar Facet Fixation System
-
Univar Solutions Appoints Austin Nichols as President of its ChemPoint Subsidiary
-
Broadcom Inc. to Announce Second Quarter Fiscal Year 2024 Financial Results on Wednesday, June 12, 2024
-
Calyx Medical Imaging Supports Groundbreaking Melanoma Treatment Approval
-
Revolutionary Learning App Brings AI 'Teachers' to Life, Preps Students for AP Exams
-
Endo Launches Enhanced TruDelivery® Ready-to-Use Product Line and Platform
-
New Netskope App for ServiceNow Modernizes Threat and Data Protection Workflows for SecOps and Incident Response Teams
-
SOUTHERN FIRST APPOINTS CHRIS ZYCH AS CHIEF FINANCIAL OFFICER
-
POLLO CAMPERO EXPANDS CHICKEN SANDWICH LINEUP WITH TWO UNIQUE NEW FLAVORS
-
ADAMA Set to Bring Innovation to the European Cereal Herbicide Segment with the Introduction of EDAPTIS®
-
TAILG Unveils 19 E-bikes at 2024 CHINA CYCLE
-
Nicolas Roussy Newton, Co-Founder and COO of BTQ Technologies, to Present Quantum Innovations at IQT Vancouver • Pacific Rim 2024
-
Hyzon Applauds Final Treasury Regulations Impacting Tax Credits for Qualified Commercial Clean Vehicles
-
NextEra Energy announces organizational changes
-
Mandalay Resources Provides Target Release Date for its First Quarter 2024 Financial Results and Conference Call
-
BOOTS CAPITAL ENCOURAGES SHAREHOLDERS TO IGNORE CROWN CASTLE'S DISTRACTING MISREPRESENTATIONS AND JUDGE DIRECTOR CANDIDATES ON THE MERITS
-
AUXLY ANNOUNCES EXPANSION INTO QUEBEC AND LAUNCHES NEW TRANSFORMATIVE PRE-ROLL AND VAPE INNOVATION
-
Relmada Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024
-
LeddarTech Announces Participation in the Sidoti Virtual Investor Conference on May 9, 2024
-
Zimmer Biomet Publishes 2023 Sustainability Report
-
Farmer Mac Reports First Quarter 2024 Results
-
NextEra Energy Partners announces organizational changes
-
The General Assembly of Siniora Food Industries Company approved the distribution of cash dividends amounting to JD 4.2 million representing 15% of its paid-in capital, and stock dividends amounting t
-
Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference
-
Soligenix to Present at Upcoming Conferences
-
Record Breaking Atlantic Hurricane Season Looms - Are People Ready?
-
SUNSTONE HOTEL INVESTORS REPORTS RESULTS FOR FIRST QUARTER 2024
-
Alpha Announces First Quarter 2024 Financial Results
-
JLL Reports Financial Results for First-Quarter 2024
-
Tiger Brokers (HK) officially launches virtual asset trading services, leading the way in Hong Kong's online brokerage industry
-
NAPCO Reports Record Revenues, Net Income and Adjusted EBITDA* for Q3 of Fiscal 2024
-
35TH ANNIVERSARY BROADCAST OF AN AMERICAN TRADITION: PBS' NATIONAL MEMORIAL DAY CONCERT LIVE FROM THE U.S. CAPITOL
-
Ginkgo Bioworks Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
-
RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035
-
Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024
-
SucceedSmart Named a 2024 TiE50 Award Winner in Recognition of its Disruptive AI-Driven Executive Recruitment Platform
-
IsoEnergy Commences Utah 2024 Exploration Program
-
Eisbach Bio announces FDA clearance of IND application for EIS-12656, a first-in-class allosteric inhibitor of ALC1
-
PACSUN SUITS UP FOR FORMULA 1® IN MIAMI WITH A NEW APPAREL COLLECTION AND INTERACTIVE EXPERIENCES
-
GIBF invests $10 Million in Nectin Therapeutics to Advance Novel Pipeline of First-in-Class Immunotherapies and Antibody Drug Conjugates
-
BioLineRx Announces Poster Presentation on Economic Model Data for APHEXDA® (motixafortide) as part of CD34+ Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma at ISPOR 2024
-
Mediar Advances First-in-Class Fibrosis Portfolio to the Clinic with First Cohort Dosing in Phase 1 trial of MTX-463 and Establishes Clinical Advisory Board
-
Scientia Vascular Announces FDA approvals for New Line of Microfabricated Neurovascular Catheters
-
BCT-Bank of Charles Town Announces Promotion of Leslie Crabill to Executive Vice President of BCT Wealth and Investments Division
